PNV · ASX

Polynovo Limited (ASX:PNV)

AU$1.52

 0.085 (5.903%)
ASX:Live
15/09/2025 04:10:02 PM
Volume Spike Hammer Bearish HALO Small HALO Ords HALO Capital Efficiency +9
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

PNV Overview

PNV Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Weak

GARP

Very Weak

MQV Small

Very Weak

Valuation

Value

Consensus

Momentum

Price

Strong

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About PNV

Website

Polynovo Limited

Telephone

61.3.8681.4050

Address

Unit 2 320 Lorimer Street Port Melbourne, Victoria (VIC) 3207

Description

Polynovo Ltd. engages in the development of medical devices, utilizing the patented polymer technology NovoSorb. It focuses on biodegradable temporizing matrix (BTM) product. It operates through the United States of America, Australia and New Zealand, and Other Countries geographical segments. The company was founded on August 12, 1998 and is headquartered in Port Melbourne, Australia.

PNV Price Chart

Key Stats

Market Cap

AU$1.01B

PE

152.30

EV/EBITDA

69.6

Dividends Overview

DIV Yield

.0%

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.93 - 2.68

Trade Value (12mth)

AU$827,175.00

1 week

3.97%

1 month

22.03%

YTD

-29.76%

1 year

-44.19%

All time high

4.08

Key Fundamentals

EPS 3 yr Growth

-1161.10%

EBITDA Margin

6.10%

Operating Cashflow

$4m

Free Cash Flow Return

4.20%

ROIC

14.40%

Interest Coverage

8.90

Quick Ratio

2.20

Other Data

Shares on Issue (Fully Dilluted)

691m

HALO Sector

Healthcare

Next Company Report Date

21-Aug-26

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

2.55

PNV Announcements

Latest Announcements

Date Announcements

15 September 25

Change in substantial holding

×

Change in substantial holding

15 September 25

Director Share Purchase - David Williams

×

Director Share Purchase - David Williams

12 September 25

Director Share Purchase - David Williams

×

Director Share Purchase - David Williams

12 September 25

Pause in Trading

×

Pause in Trading

12 September 25

Trading Halt

×

Trading Halt

12 September 25

Chronic diabetic-related wound study results

×

Chronic diabetic-related wound study results

11 September 25

Change in substantial holding

×

Change in substantial holding

11 September 25

Director Share Purchase - David Williams

×

Director Share Purchase - David Williams

11 September 25

Director Share Purchase - Leon Hoare

×

Director Share Purchase - Leon Hoare

08 September 25

FY25 Annual Report

×

FY25 Annual Report

05 September 25

S&P DJI Announces September 2025 Quarterly Rebalance

×

S&P DJI Announces September 2025 Quarterly Rebalance

02 September 25

U.S. Medicare Reimbursement Proposal

×

U.S. Medicare Reimbursement Proposal

02 September 25

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

01 September 25

Trading Halt

×

Trading Halt

29 August 25

Becoming a substantial holder

×

Becoming a substantial holder

28 August 25

Change in substantial holding

×

Change in substantial holding

26 August 25

Webcast Recording - FY25 Results Presentation

×

Webcast Recording - FY25 Results Presentation

25 August 25

Appendix 4E and FY25 Financial Statements

×

Appendix 4E and FY25 Financial Statements

25 August 25

FY25 Results Presentation

×

FY25 Results Presentation

25 August 25

Appendix 4G

×

Appendix 4G

25 August 25

Corporate Governance Statement

×

Corporate Governance Statement

13 August 25

FY25 Results Webcast Link

×

FY25 Results Webcast Link

12 August 25

Change in substantial holding

×

Change in substantial holding

11 August 25

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

08 August 25

Change in substantial holding

×

Change in substantial holding

07 August 25

Becoming a substantial holder

×

Becoming a substantial holder

PNV Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.01 0.01 0.02 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.01 0.01 0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -300.0 205.6 151.3 Lock Lock Lock
     PE X Lock Lock Lock Lock 13,268.0 357.9 152.3 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 379.8 337.7 69.6 Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.00 0.01 0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 0.00 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 56.3 871.6 23.2 Lock Lock Lock
     Yield % Lock Lock Lock Lock -0.7 0.1 -1.2 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.09 0.10 0.12 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.09 0.10 0.12 Lock Lock Lock
     Growth % Lock Lock Lock Lock 277.5 10.9 15.9 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 684 700 693 Lock Lock Lock
Basic m Lock Lock Lock Lock 684 690 691 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Income Statement
Sales $m Lock Lock Lock Lock 65 103 127 Lock Lock Lock
     Growth % Lock Lock Lock Lock 57.4 58.2 23.3 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 26 35 40 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 19 36 45 Lock Lock Lock
     Growth % Lock Lock Lock Lock 19.1 86.7 24.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock 29.6 35.0 35.2 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 70 65 65 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -4 4 8 Lock Lock Lock
     Growth % Lock Lock Lock Lock -353.3 200.0 100.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -6.0 3.8 6.1 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 2 3 3 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -6 1 4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -2,309.8 118.8 285.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -9.5 1.1 3.5 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -5 2 8 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 -4 -6 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -5 5 13 Lock Lock Lock
     Growth % Lock Lock Lock Lock -312.9 206.8 151.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -7.5 5.1 10.4 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -6 5 4 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 2 3 14 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -2 -3 -14 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 48 -3 -2 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -7 2 -10 Lock Lock Lock
     Growth % Lock Lock Lock Lock -192.8 129.4 -559.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.1 0.0 -0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 47 46 34 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 93 109 129 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 14 13 15 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -31 -31 -16 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 27 37 45 Lock Lock Lock
Equity $m Lock Lock Lock Lock 65 72 83 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 80 85 98 Lock Lock Lock
     Growth % Lock Lock Lock Lock 195.4 6.8 15.3 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -5.3 4.8 10.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -7.5 7.3 15.9 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -11.2 1.4 4.8 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -9.3 6.4 14.4 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -11.1 6.2 4.2 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Leverage
Interest Cover X Lock Lock Lock Lock -5.5 5.4 8.9 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 7.9 -7.8 -2.1 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -47.2 -42.4 -19.8 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 5.3 3.4 2.8 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 5.0 3.0 2.2 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 69.6 58.0 43.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -46.8 21.9 13.9 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 6.5 5.9 5.5 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 13.0 9.9 7.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 1.2 1.8 2.6 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 4.2 6.2 5.5 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.7 0.9 1.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.7 0.9 1.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -7.6 1.7 5.9 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -5.3 1.6 5.8 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 -207.5 -75.7 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -5.3 4.8 10.3 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.4 1.5 1.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -7.5 7.3 15.9 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -7.5 7.3 15.9 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 28.1 36.7 52.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 56.3 62.1 66.4 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 84.4 98.8 118.3 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 17.6 23.3 27.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 66.8 75.5 90.6 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

.0%

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

12.27%

Value ($M)

125

Prior Change

0.20%

7 Day Change

0.20%

1 Month Change

0.60%

3 Month Change

1.70%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

PNV Shortsell

Frequently Asked Questions

The current share price of Polynovo Limited (PNV:ASX) is AU$1.52.
The 52-week high share price for Polynovo Limited (PNV:ASX) is AU$2.68.
The 52-week low share price for Polynovo Limited (PNV:ASX)? is AU$0.93.
The current TTM dividend payout for Polynovo Limited (PNV:ASX) is 0.00.
Polynovo Limited (PNV:ASX) does not pay a dividend.
Polynovo Limited (PNV:ASX) has a franking level of 0.0%.
Polynovo Limited (PNV:ASX) is classified in the Healthcare.
The current P/E ratio for Polynovo Limited (PNV:ASX) is 152.30.
The current share price of Polynovo Limited (PNV:ASX) is AU$1.52.
The 52-week high share price for Polynovo Limited (PNV:ASX) is AU$2.68.
The 52-week low share price for Polynovo Limited (PNV:ASX)? is AU$0.93.
The current TTM dividend payout for Polynovo Limited (PNV:ASX) is 0.00.
Polynovo Limited (PNV:ASX) does not pay a dividend.
Polynovo Limited (PNV:ASX) has a franking level of 0.0%.
Polynovo Limited (PNV:ASX) is classified in the Healthcare.
The current P/E ratio for Polynovo Limited (PNV:ASX) is 152.30.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.